Pharma companies were fairly active in digital health in the third quarter of 2017, especially in the areas of diabetes and respiratory disease. Read on for a round-up of notable events.
Diabetes management
Abbott Diabetes Care had a big quarter for its Freestyle Libre system, both in the United States and abroad. First, in July, Abbott and Bigfoot Biomedical entered into an agreement to develop...
This quarter’s news from digital health payers consisted of CMS updates, new information on a few tech-centric insurer deals, and a spattering of employer insurance headlines. Read on for MobiHealthNews’ full roundup for Q3 2017.
CMS news
Potentially the most wide-reaching public insurance development of the quarter was the unanimous passage of Senate Bill 870, the Creating High-Quality Results...
In the third quarter of 2017, we saw a lot of news from hospitals launching new digital health initiatives. Many hospitals and health systems partnered with digital health startups for pilots or full deployments, and a few launched their own offerings developed in house. Large health systems also participated in research activities to validate digital health technologies. Read on for a round-up...
Led by a new commissioner in Dr. Scott Gottlieb, the FDA had a busy few months with a handful of digital and mobile technologies getting cleared in the third quarter of 2017. Consumer-focused diabetes and pain management offerings were prominent, but but by and large the clearances hit a multitude of clinical concerns and, of note, even included the first software-only digital therapeutic....
While the third quarter’s digital health funding may not have met the staggering scale of its predecessor, MobiHealthNews still tracked 53 deals during July, August, and September totaling $578.55 million. Below, we’ve listed all of the companies that raised equity from investors along with links to MobiHealthNews’ coverage at the time. Deals are ranked in order from largest to smallest. If...
